Science Silenced What they buried — aggregated daily
Suppressed research daily
Medical & scientific
No pharma funding
Science SILENCED The studies they didn't want you to read.
No approved narratives
No pharma ads
No censored conclusions
■  Thomas Seyfried — cancer as metabolic disease — zero pharma funding  ■  Chris Palmer — mental illness as mitochondrial dysfunction — NIMH not interested  ■  Dale Bredesen — Alzheimer's reversal protocol — no drug at the end  ■  Rapamycin — longevity extension — off patent — ignored  ■  MAPS — MDMA for PTSD — privately funded for decades  ■  Thomas Seyfried — cancer as metabolic disease — zero pharma funding  ■  Chris Palmer — mental illness as mitochondrial dysfunction — NIMH not interested  ■  Dale Bredesen — Alzheimer's reversal protocol — no drug at the end  ■  Rapamycin — longevity extension — off patent — ignored  ■  MAPS — MDMA for PTSD — privately funded for decades  
■ Pillar 04 of 05
Uncaged.
The research happening outside the captured system. No NIH gatekeeping. No pharma funding because there's no patent at the end of it. Metabolic cancer therapies. Longevity compounds. Psychedelic medicine. The microbiome. Funded by private donors, military grants, and independent institutions — producing results the establishment ignores.
—Stories tracked
$0Pharma funding accepted
67%MDMA PTSD remission rate
← Back to Latest
Last updated: —

These researchers are doing the work pharma won't fund because there's no patentable drug at the end of it. They are funded by private donors, military grants, university endowments, and their own conviction. The results are remarkable. The establishment is not interested. We are.

Key Researchers to Watch
Thomas Seyfried PhD
Boston College — Metabolic Cancer
Cancer as metabolic disease. Ketogenic + fasting press-pulse protocols. Results in glioblastoma NIH won't touch. Zero pharma money.
Chris Palmer MD
Harvard — Metabolic Psychiatry
Brain Energy theory — mitochondrial dysfunction as root cause of all mental illness. Remission cases in schizophrenia and bipolar. NIMH not interested.
Dale Bredesen MD
Buck Institute — Alzheimer's
ReCODE protocol — 36-point lifestyle intervention showing cognitive reversal in early Alzheimer's. Not a pill. Pharma has zero interest.
David Sinclair PhD
Harvard — Longevity Science
NAD+, sirtuins, epigenetic reprogramming. Animal models showing aging reversal. Partially outside NIH orthodoxy. Results extraordinary.
Matt Kaeberlein PhD
Univ. Washington — Rapamycin
Dog Aging Project — rapamycin longevity extension. Off-patent, cheap, ignored by pharma. Privately funded. Remarkable lifespan data.
MAPS / Rick Doblin
MAPS — Psychedelic Medicine
MDMA for PTSD — Phase 3 trials. 67-71% no longer met PTSD criteria. Privately funded for decades because DEA Schedule I blocked NIH funding.
Latest Uncaged Stories
Loading...
All Uncaged Stories
Loading...